As of Mar 20
| -0.23 / -1.28%|
The 24 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 18.00, with a high estimate of 25.00 and a low estimate of 6.00. The median estimate represents a +1.81% increase from the last price of 17.68.
The current consensus among 31 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.